What a Positive Antibody Test Does and Does Not Tell You About Immunity

A positive antibody test tells you one thing with confidence: at some point your immune system met a pathogen or a vaccine antigen and made antibodies against it. It does not tell you that you are protected today. The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention both advise against using serology to judge immunity, because the authorized tests were never validated to measure protection. Read plainly, a reactive result is a record that something happened, not a promise about what happens next.

Key points#

• A positive serology result confirms prior contact with an antigen, from infection or vaccination. It is a fact about the past.
• FDA and CDC state that authorized antibody tests are not validated to evaluate immunity or protection, before or after vaccination.
• Antibodies are one layer of a many-part defense that also includes T cells and memory cells, which serology does not measure.
• Most public antibody tests report binding antibodies, not the neutralizing kind, and have no agreed cutoff that means "immune."
• A validated correlate of protection is a specific, hard-earned lab threshold. Ordinary antibody tests are not that.

Start with the question the test is answering#

It helps to notice that a serology test and a protection question are two different questions wearing similar clothes. Serology asks, "Are antibodies to this antigen present in this blood sample?" Protection asks, "Will this person resist disease if the pathogen arrives?" The first is a laboratory observation. The second is a clinical prediction that depends on the whole immune system over time.

The FDA frames the boundary in exactly these terms. A positive antibody result can help identify people who may have had a prior SARS-CoV-2 infection, but the agency states that these tests do not tell you whether you have immunity that will keep you from getting COVID-19. Most widely used assays are built to detect binding antibodies. They register that your body saw an antigen and responded. They were not designed to certify that the antibodies present can stop a live virus.

Why one blood draw cannot settle immunity#

The immune response is layered, and serology samples only one layer at one moment. Innate defenses act first and keep no memory. Antibodies, made by B cells, are the humoral arm. T cells coordinate the response and destroy infected cells as the cellular arm. Memory B cells and memory T cells hold the template for a faster reaction months or years later. A titer captures a snapshot of circulating antibody, and nothing else.

That single snapshot can mislead in both directions. Circulating antibody often declines in the months after infection or vaccination while memory cells persist, so a low or even negative titer does not prove that protection has faded. Running the other way, the mere presence of antibodies does not guarantee they are the functional, neutralizing kind, present at a level that actually blocks infection. Binding antibodies and neutralizing antibodies are not the same thing, and standard serology usually measures the former.

The idea most tests are missing: a correlate of protection#

Immunology reserves a precise term for a lab value that reliably predicts protection: a correlate of protection. It is a measurable immune marker shown, through careful population studies, to track with a defined level of clinical protection above a validated threshold. Establishing one is demanding, and it is specific to a particular assay paired with a particular disease.

Most antibody tests offered to the public are not validated correlates of protection. They return a signal with no agreed cutoff that means "immune." Results from different manufacturers use different units and calibrators, so a number from one assay cannot be lined up against a number from another. The FDA states that the currently authorized antibody tests are not validated to evaluate immunity or protection. Reading a protective status into an ordinary titer treats a simple presence-or-absence signal as though it were a threshold that, for that test, was never established.

What the agencies actually said, and why#

In a safety communication first issued in May 2021, the FDA advised that results from authorized SARS-CoV-2 antibody tests should not be used to evaluate a person's level of immunity or protection at any time, and especially after vaccination. The reasoning has two parts: the tests were not validated for that purpose, and a misread result can lead someone to take fewer precautions than their real risk warrants. The CDC's interim guidelines land in the same place, noting that antibody testing is not recommended to assess immunity after COVID-19 vaccination, nor to decide whether an unvaccinated person needs a vaccine, because none of the authorized tests were validated to measure protection.

One assay detail makes the mismatch concrete. COVID-19 mRNA vaccines prompt antibodies against the spike protein, while some serology assays are built to detect antibodies against the nucleocapsid protein, a marker of natural infection. A person who responded well to vaccination can test negative on a nucleocapsid assay. The result is not an error. It is simply answering a different question than the one being asked.

Reading your own result without over-reading it#

If your antibody test is positive, the honest and useful interpretation is a modest one: your immune system met the antigen and mounted a response. That is worth knowing. It is not a signal to drop recommended precautions, and it is not a substitute for the vaccination schedule your clinician follows, which rests on population outcome data rather than individual titers.

A helpful way to hold it: an antibody is a footprint on the doormat, evidence that a visitor once passed through. Whether the door is locked now depends on the entire security system, and on whether a given test has ever been tied to real-world protection. Until a test carries that validation, a positive result is best read as a record of prior contact, not a certificate of immunity.